Logo image of UCU.CA

UCORE RARE METALS INC (UCU.CA) Stock Fundamental Analysis

TSX-V:UCU - CA90348V3011 - Common Stock

4.01 CAD
+0.16 (+4.16%)
Last: 8/28/2025, 7:00:00 PM
Fundamental Rating

1

Overall UCU gets a fundamental rating of 1 out of 10. We evaluated UCU against 791 industry peers in the Metals & Mining industry. Both the profitability and financial health of UCU have multiple concerns. UCU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

UCU had negative earnings in the past year.
UCU had a negative operating cash flow in the past year.
In the past 5 years UCU always reported negative net income.
In the past 5 years UCU always reported negative operating cash flow.
UCU.CA Yearly Net Income VS EBIT VS OCF VS FCFUCU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of UCU (-23.34%) is comparable to the rest of the industry.
UCU has a Return On Equity (-35.27%) which is in line with its industry peers.
Industry RankSector Rank
ROA -23.34%
ROE -35.27%
ROIC N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
UCU.CA Yearly ROA, ROE, ROICUCU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

UCU does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UCU.CA Yearly Profit, Operating, Gross MarginsUCU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

2

2. Health

2.1 Basic Checks

UCU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, UCU has more shares outstanding
Compared to 1 year ago, UCU has a worse debt to assets ratio.
UCU.CA Yearly Shares OutstandingUCU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
UCU.CA Yearly Total Debt VS Total AssetsUCU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 7.70 indicates that UCU is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.70, UCU is in the better half of the industry, outperforming 68.27% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that UCU is not too dependend on debt financing.
UCU's Debt to Equity ratio of 0.31 is on the low side compared to the rest of the industry. UCU is outperformed by 70.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 7.7
ROIC/WACCN/A
WACCN/A
UCU.CA Yearly LT Debt VS Equity VS FCFUCU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

UCU has a Current Ratio of 0.43. This is a bad value and indicates that UCU is not financially healthy enough and could expect problems in meeting its short term obligations.
UCU has a Current ratio of 0.43. This is in the lower half of the industry: UCU underperforms 71.93% of its industry peers.
UCU has a Quick Ratio of 0.43. This is a bad value and indicates that UCU is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.43, UCU is not doing good in the industry: 70.04% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.43
UCU.CA Yearly Current Assets VS Current LiabilitesUCU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

0

3. Growth

3.1 Past

UCU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.93%.
EPS 1Y (TTM)-11.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UCU. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UCU.CA Price Earnings VS Forward Price EarningsUCU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UCU.CA Per share dataUCU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

UCU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UCORE RARE METALS INC

TSX-V:UCU (8/28/2025, 7:00:00 PM)

4.01

+0.16 (+4.16%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)09-01 2025-09-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap356.97M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.88
P/tB 10.89
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS0.45
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.34%
ROE -35.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.84%
ROA(5y)-13.5%
ROE(3y)-19.73%
ROE(5y)-16.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41.85%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.43
Altman-Z 7.7
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1731.92%
Cap/Depr(5y)1254.27%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y19.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-92.98%
OCF growth 3YN/A
OCF growth 5YN/A